15 Feb 2018

IAC RESEARCH LETTER OF INTENT DEADLINE APRIL 2

  The deadline for submitting a letter of tenant to submit a full research program proposal to be funded by the Intersocietal Accreditation Commission (IAC) is April 2. The IAC Research Committee will be awarding one-year grants or continuation grants up to a maximum of $75,000 (including institutional overhead). This

0
08 Feb 2018

16th IVC TO HOST 800+ VEIN CARE SPECIALISTS TO LEARN LATEST DEVELOPMENTS IN VENOUS DISEASE MANAGEMENT

  By Larry Storer The International Vein Congress (IVC) will host its 16th annual meeting April 19-21 in Miami Beach, Fla., at the Loews Miami Beach Hotel in collaboration with the Society for Vascular Surgery (SVS). Jose I. Almeida, MD, FACS, RPVI, RVT, who founded the conference and has directed

0
30 Jan 2018

ACP OFFERS ONE-DAY PRACTICE MANAGEMENT COURSE

  A Practice Management Course, a one-day series covering topics vital to a vein practice, will be conducted by the American College of Phlebology from 8-5 p.m. March 3 at the Denver Airport Marriott at Gateway Park in Aurora, Colo. Register at https://netforum.avectra.com/eweb/DynamicPage.aspx?WebCode=LoginRequired&Site=ACP

0
12 Jan 2018

CENTERLINE BIOMEDICAL  COMPLETES FIFTH STUDY ON IOPS SURGICAL NAVIGATION SYSTEM AT CLEVELAND CLINI

  Endovascular navigation startup Centerline Biomedical has successfully completed a fifth preclinical study at Cleveland Clinic facilities to see how its surgical navigation system, the Intra-Operative Positioning System (IOPS), will perform in the marketplace. The study demonstrated its ability to track IOPS instruments precisely and efficiently with enhanced three-dimensional (3D) visualization and

0
11 Jan 2018

FDA APPROVES XABLECATH BLUNT TIP SUPPORT CATHETER

  XableCath’s blunt tip support catheter has received clearance from the U.S. Food and Drug Administration (FDA). In two clinical investigator-led studies, the device was demonstrated to be a safe, effective, and easy-to-use device, enabling therapeutic options for patients with PAD,” said Johannes Dahm, MD and director of Interventional Cardiology

0
06 Jan 2018

STUDY SHOWS STEM CELL TRANSPLANT IS BETTER THAN DRUG THERAPY FOR SCLERODERMA

Photo courtesy of American College of Rheumatology   Adding irradiation before transplant improves long-term results and should change practice    Scleroderma with internal organ involvement is a debilitating and lethal autoimmune disorder with few effective treatments. But a study led by Duke Health researchers has found new cause for optimism using an

0
15 Dec 2017

AMERICAN VEIN & VASCULAR INSTITUTE ADDS NEW PHYSICIAN

John Joseph Randono, MD, has joined the phlebology staff of American Vein & Vascular Institute, a network of eight vein and arterial diagnosis and treatment centers in Colorado and Texas. Dr. Randono has more than 30 years medical experience, specifically as a cardiac and thoracic vascular surgeon, and as a

0
14 Dec 2017

EX-EMPLOYEE CHARGES JOHN HOPKINS WITH SELECTIVE ADMISSION FOR FINANCIAL GAIN

If you live in California, Texas or New York, you might have a better chance of being treated at world-class John Hopkins than the man who lives just down North Wolfe Street in Baltimore. Anthony C. Campos, a former supervisor in the Johns Hopkins Health System Corporation’s patient appointments department,

0
11 Dec 2017

PHYSICIAN CEO LOSES JOB OVER ALLOWING PHYSICIAN TO SLIDE FOLLOWING SEXUAL HARASSMENT, BULLYING COMPLAINTS

  The CEO of a Massachusetts health center resigned Dec. 10 under pressure following a report that he allowed a prominent doctor to stay on the job for years despite allegations he sexually harassed and bullied staff members.   As complaints of sexual harassment continue to cost prominent people in

0
11 Dec 2017

4 DOCTORS AMONG 20 CHARGED WITH BILKING MEDICARE, MEDICAID AND OTHER MANAGED CARE ORGANIZATIONS OUT OF $146 MILLION

Twenty people — four of whom are doctors — are facing charges related to a massive fraud scheme that bilked Medicare, Medicaid and other managed care organizations out of $146 million. Prosecutors from the Brooklyn District Attorneys Office said the defendants ran an enterprise in which recruiters offered cash to low-income and

0